消息
2020/11/7
冠狀病毒相關著作
(2020/11/17 更新)
昱星生物科技與冠狀病毒相關的研究成果:
昱星生物科技與冠狀病毒相關的研究成果:
- Wang S-M, Huang K-J, Wang C-T. Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release. J Med Virol. 2019;91(10):1743-50.
- Wang S-M, Huang K-J, Wang C-T. BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface. Virology. 2014;449:287-96.
- Tseng Y-T, Wang S-M, Huang K-J, Wang C-T. SARS-CoV envelope protein palmitoylation or nucleocapid association is not required for promoting virus-like particle production. Journal of Biomedical Science. 2014;21(1):34.
- Tseng Y-T, Chang C-H, Wang S-M, Huang K-J, Wang C-T. Identifying SARS-CoV Membrane Protein Amino Acid Residues Linked to Virus-Like Particle Assembly. PLOS ONE. 2013;8(5):e64013.
- Lo YS, Lin SY, Wang SM, Wang CT, Chiu YL, Huang TH, Hou MH. Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein. FEBS Lett. 2013;587(2):120-7.
- Tseng Y-T, Wang S-M, Huang K-J, Lee AI-R, Chiang C-C, Wang C-T. Self-assembly of Severe Acute Respiratory Syndrome Coronavirus Membrane Protein. Journal of Biological Chemistry. 2010;285(17):12862-72.
- Wang S-M, Wang C-T. APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein. Virology. 2009;388(1):112-20.
- Wang S-M, Chang Y-F, Chen Y-MA, Wang C-T. Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain. Journal of Biomedical Science. 2008;15(6):719.